- Primary & Secondary Syphilis
- Others
Syphilis Testing Market size was valued at USD 1,538.4 Million in 2023 and is poised to grow at a significant CAGR of 8.5% from 2023-2029. Syphilis is a sexually transmitted disease caused by Treponema pallidum bacteria. Syphilis tests are used for screening and detection of antibodies against bacteria into the patient’s blood. There are various complications related to syphilis infection, such as infertility in both, men and women, ectopic pregnancy, cervical cancer in women and congenital mortality, and infections. The Primary segment is anticipated to grow at a significant CAGR over the forecast years. The first stage happens two to 12 weeks after exposure to the bacteria. During this stage, a smooth, red sore called a chancre develops on the genitals or in the mouth. It goes away on its own in a few weeks or months. A chancre is small and usually painless, so you may not even know it’s there. Blood tests can confirm the presence of antibodies that the body produces to fight infection. The antibodies to the syphilis-causing bacteria remain in your body for years, so the test can be used to determine a current or past infection which can anticipated the growth of syphilis testing market. Rising public awareness about syphilis treatment, increase in the occurrence of sexually transmitted disease, increasing government funding or investments on STD testing, Impact of social taboos and stigmas are a few factors driving the industry's growth over the forecasting period.
Syphilis Testing Market Key Developments:
Study Period
2024-2030Base Year
2023CAGR
8.5%Largest Market
North AmericaFastest Growing Market
Asia Pacific
The market for syphilis testing is expanding because of rising rates of sexual interaction, higher prevalence of STDs, and technological breakthroughs in syphilis testing. Additionally, the global increase in the elderly population spurs market expansion. Lack of health insurance and little consumer awareness of the advantages of tests restrain market expansion. Higher adoption rates for technologically advanced screening tests, active measures from the governments and private associations, and growing awareness for the syphilis infections largely contribute to the growth of the market.
By Product Type
By Location of Testing
By Geography
The syphilis testing market size was valued at USD 1,538.4 million in 2022
The acupuncture market syphilis testing market key players are: Abbott Laboratories Becton, Dickinson and Co. Bio-Rad Laboratories Inc. Danaher Corp. DRG International Inc F. Hoffmann-La Roche AG Hologic Inc. Omega Diagnostics Group Plc Siemens Healthineers AG Thermo Fisher Scientific Inc.
The syphilis testing market has been classified into North America, Asia Pacific, Europe, Latin America, Middle East and Africa, and the rest of MEA.
1. Executive Summary |
2. Global Syphilis Testing Market Introduction |
2.1.Global Syphilis Testing Market - Taxonomy |
2.2.Global Syphilis Testing Market - Definitions |
2.2.1.Product Type |
2.2.2.Location of Testing |
2.2.3.Geography |
2.2.4.Region |
3. Global Syphilis Testing Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Product Landscape |
3.6. New Product Launches |
3.7. Impact of COVID 19 on Market |
4. Global Syphilis Testing Market Analysis, 2018 - 2022 and Forecast 2023 - 2029 |
4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Syphilis Testing Market By Product Type, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
5.1. Primary & Secondary Syphilis |
5.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.3. Market Opportunity Analysis |
5.2. Others |
5.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
6. Global Syphilis Testing Market By Location of Testing, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
6.1. Laboratory testing |
6.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Point of care (POC) testing |
6.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
7. Global Syphilis Testing Market By Geography, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. The Asia Pacific |
7.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. MEA |
7.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
7.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
8. Global Syphilis Testing Market By Region, 2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
8.1. North America |
8.1.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.1.3. Market Opportunity Analysis |
8.2. Europe |
8.2.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.2.3. Market Opportunity Analysis |
8.3. Asia Pacific (APAC) |
8.3.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.3.3. Market Opportunity Analysis |
8.4. Middle East and Africa (MEA) |
8.4.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.4.3. Market Opportunity Analysis |
8.5. Latin America |
8.5.1. Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029, (Sales Value USD Million) |
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
8.5.3. Market Opportunity Analysis |
9. North America Syphilis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
9.1. Product Type Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.1.1.Primary & Secondary Syphilis |
9.1.2.Others |
9.2. Location of Testing Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.2.1.Laboratory testing |
9.2.2.Point of care (POC) testing |
9.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.3.1.North America |
9.3.2.Europe |
9.3.3.The Asia Pacific |
9.3.4.Latin America |
9.3.5.MEA |
9.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
9.4.1.United States of America (USA) |
9.4.2.Canada |
10. Europe Syphilis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
10.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.1.1.Primary & Secondary Syphilis |
10.1.2.Others |
10.2. Location of Testing Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.2.1.Laboratory testing |
10.2.2.Point of care (POC) testing |
10.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.3.1.North America |
10.3.2.Europe |
10.3.3.The Asia Pacific |
10.3.4.Latin America |
10.3.5.MEA |
10.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
10.4.1.Germany |
10.4.2.France |
10.4.3.Italy |
10.4.4.United Kingdom (UK) |
10.4.5.Spain |
10.4.6.Rest of EU |
11. Asia Pacific (APAC) Syphilis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
11.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.1.1.Primary & Secondary Syphilis |
11.1.2.Others |
11.2. Location of Testing Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.2.1.Laboratory testing |
11.2.2.Point of care (POC) testing |
11.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.3.1.North America |
11.3.2.Europe |
11.3.3.The Asia Pacific |
11.3.4.Latin America |
11.3.5.MEA |
11.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
11.4.1.China |
11.4.2.India |
11.4.3.Australia and New Zealand (ANZ) |
11.4.4.Japan |
11.4.5.Rest of APAC |
12. Middle East and Africa (MEA) Syphilis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
12.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.1.1.Primary & Secondary Syphilis |
12.1.2.Others |
12.2. Location of Testing Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.2.1.Laboratory testing |
12.2.2.Point of care (POC) testing |
12.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.3.1.North America |
12.3.2.Europe |
12.3.3.The Asia Pacific |
12.3.4.Latin America |
12.3.5.MEA |
12.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
12.4.1.GCC Countries |
12.4.2.South Africa |
12.4.3.Rest of MEA |
13. Latin America Syphilis Testing Market ,2018 - 2022 and Forecast 2023 - 2029 (Sales Value USD Million) |
13.1. Product Type Analysis and Forecast by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.1.1.Primary & Secondary Syphilis |
13.1.2.Others |
13.2. Location of Testing Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.2.1.Laboratory testing |
13.2.2.Point of care (POC) testing |
13.3. Geography Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.3.1.North America |
13.3.2.Europe |
13.3.3.The Asia Pacific |
13.3.4.Latin America |
13.3.5.MEA |
13.4. Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) |
13.4.1.Brazil |
13.4.2.Mexico |
13.4.3.Rest of LA |
14. Competition Landscape |
14.1. Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) |
14.2.1.Abbott Laboratories |
14.2.2.Becton, Dickinson and Co. |
14.2.3.Bio-Rad Laboratories Inc. |
14.2.4.Danaher Corp. |
14.2.5.DRG International Inc |
14.2.6.F. Hoffmann-La Roche AG |
14.2.7.Hologic Inc. |
14.2.8.Omega Diagnostics Group Plc |
14.2.9.Siemens Healthineers AG |
14.2.10.Thermo Fisher Scientific Inc. |
15. Research Methodology |
16. Appendix and Abbreviations |